BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Wang Y, Wang Y, Wang N, Duan Q, Wang S, Liu M, Bilal MA, Zheng Y. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways. J Invest Dermatol 2021:S0022-202X(21)01670-5. [PMID: 34358528 DOI: 10.1016/j.jid.2021.07.163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Wang X, Ding Y, Hui N, Su B, Yang M. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Eur J Med Res 2022;27:216. [DOI: 10.1186/s40001-022-00854-1] [Reference Citation Analysis]
2 Sun Q, Liu X, Peng Q, Hu L, Jiang X, Cui D. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-12. [DOI: 10.1155/2022/1584397] [Reference Citation Analysis]